MONDAY, Oct. 5, 2020 -- Research following patients for nearly three decades finds that surgery plus radiation beats surgery alone for women with ductal carcinoma in situ (DCIS) -- a common, early form of breast cancer that can become invasive cancer.
However, the study also found that any survival advantage for the combo treatment appears to fade over the long term.
FRIDAY, Sept. 25, 2020 -- Among breast cancer patients in the United States, Black women are more likely to start treatment later and to have a longer treatment period than white women, new research shows.
For the study, researchers at the University of North Carolina at Chapel Hill analyzed data from more than 2,800 patients (about equal numbers of Black women and white women) with stage 1 to 3 breast cancer in the Carolina Breast Cancer Study.
TUESDAY, Sept. 22, 2020 -- Women diagnosed with an early, highly treatable form of breast cancer still face a higher-than-normal risk of eventually dying from the disease, a large new study finds.
The study looked at women with ductal carcinoma in situ (DCIS), where cancer cells form in the lining of the milk ducts but have not yet invaded the breast tissue. Sometimes it's called a "pre-cancer," other times a "noninvasive breast cancer" -- terms that can be confusing, and partly reflect the fact that DCIS is not fully understood.
MONDAY, Aug. 17, 2020 -- Women with early-stage breast cancer whose surgery has been postponed during the coronavirus pandemic need not worry about the delay, new study findings suggest.
A longer time from diagnosis to surgery doesn't affect overall survival of women with early-stage tumors, the researchers found. They also said a delay didn't lower survival among women with estrogen-sensitive, early-stage breast cancer who received neoadjuvant endocrine therapy before their surgery.